Chester County News and Community Website
WASHINGTON, D.C. — The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients’ access to competing lower-cost drugs. The …
FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs Read More WASHINGTON, D.C. — The Federal Trade Commission says it has recently launched an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information and …
FTC Launches Inquiry Into Prescription Drug Middlemen Industry Read More
WASHINGTON, D.C. — The Federal Trade Commission says that it is requiring – as a condition of Hikma Pharmaceuticals PLC’s $375 million acquisition of Custopharm, Inc. – that Custopharm’s parent company …
Federal Trade Commission Preserves Competition for Development and Marketing of Steroid Injectable Drug Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued a final guidance, entitled “Compounding Animal Drugs from Bulk Drug Substances,” that will help protect animal health by recognizing …
FDA Issues Final Guidance on Animal Drug Compounding from Bulk Drug Substances Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in …
FDA Takes Steps to Increase Racial and Ethnic Diversity in Clinical Trials Read More
HARRISBURG, PA — On Thursday, AARP Pennsylvania State Director Bill Johnston-Walsh joined Senator Bob Casey virtually to highlight the need for Congress to lower prescription drug prices and deliver a petition signed by …
AARP Pennsylvania and Senator Casey Speak Out About Need for Lower Prescription Drug Prices Read More
EXTON, PA — Clayton Pharmaceuticals announced that they recently received FDA approval for Sucralfate Oral Suspension with Competitive Generic Therapy (CGT) designation.
Clayton Pharmaceuticals and VistaPharm Receive FDA Approval for Sucralfate Oral Suspension Read More
BERWYN, PA — Inc. magazine recently revealed that AscellaHealth, a global specialty pharmacy and healthcare solutions company, is No. 54 on its third annual Inc. 5000 Regionals: Northeast list, the most …
AscellaHealth Ranks No. 54 on Inc. Magazine’s List of the Northeast’s Fastest-Growing Private Companies Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX) recently announced the initiation of a clinical study evaluating the safety and pharmacokinetics (PK) of ANJESO (meloxicam) injection in pediatric patients (ages …
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO in Pediatric Patients Following Surgery Read More BERWYN, PA — AscellaHealth forecasts key trends for Specialty Pharmacy (SP) in 2022, including 1) continued utilization and rising costs of specialty agents, 2) emergence of ultra-high-cost specialty agents and cell/gene …
AscellaHealth Highlights 2022 Key Trends in Specialty Pharmacy Read More